期刊
PROCESS BIOCHEMISTRY
卷 58, 期 -, 页码 326-332出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.procbio.2017.04.014
关键词
6,6 '-Bieckol; Angiotensin I-converting enzyme (ACE); Nitric oxide (NO); Molecular docking; Antihypertension
资金
- Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2015R1D1A1A01061334]
- Marine Biotechnology Program - Ministry of Oceans and Fisheries, Republic of Korea [20150220]
- National Research Foundation of Korea [2015R1D1A1A01061334] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
In the present study, the effects of 6,6'-bieckol isolated from Ecklonia cava on angiotensin I-converting enzyme (ACE) inhibition and nitric oxide (NO) production, and the inhibitor's binding modes using the crystal structure of ACE were examined. The effects of 6,6'-bieckol on systolic blood pressure (SBP) after meals were also investigated. We predicted the 3D structure of ACE and used a docking algorithm to understand the binding between ACE and 6,6'-bieckol. The molecular docking study revealed that ACE inhibitory activity of 6,6'-bieckol was mainly attributed to the hydrogen bond interactions (Lys454, His353, Glu162, G1u376, Glu384 and Glu411) and Pi interactions (Lys511 and His513) between ACE and 6,6'-bieckol. 6,6'-bieckol significantly increased the production of nitric oxide (NO) and by phosphorylating endothelial nitric oxide synthase (eNOS) in human endothelial cells. Furthermore, antihypertensive effect in spontaneously hypertensive rats (SHRs) also revealed that oral administration of the compound can down-regulate (28.6 mmHg in 6 h) systolic blood pressure (SBP).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据